Course

Postpartum Hemorrhage Management and Care

Course Highlights


  • In this course we will learn about postpartum hemorrhage management, and why it is important for nurses to understand proper assessments, treatments, and recovery phases.
  • You’ll also learn the basics of the pathophysiology of postpartum hemorrhages.
  • You’ll leave this course with a broader understanding of how to recognize the signs and symptoms of postpartum hemorrhages in patients.

About

Contact Hours Awarded: 2

Morgan Curry

Course By:
Devon Capristo MSN, FNP-C

Begin Now

Read Course  |  Complete Survey  |  Claim Credit

Read and Learn

The following course content

Postpartum hemorrhage is the leading cause of maternal death, and the United States currently has a startling hemorrhage rate that’s responsible for 12% of maternal deaths (3). Along with accurate recognition and assessments, proper postpartum hemorrhage management, treatment, and education can actively work toward reducing the risk of maternal deaths from hemorrhages.  

Introduction

The processes of labor and birth receive a lot of discussion including delivery and induction methods, birth plans, pain control, complications, and much more. With postpartum hemorrhages on the rise in the United States, there is an urgency to focus on management and treatment. Postpartum hemorrhage (PPH) is a complication of birth but is preventable through early recognition, assessment, treatment, patient education, and follow-up. PPH accounts for 11.4% of maternal mortality cases in the United States despite the ample resources available in this country. (4). To prevent additional maternal deaths, nurses need to remain educated on this fatal condition.   

Pathophysiology of Postpartum Hemorrhages

Hemorrhage occurring in the postpartum period can occur after a woman gives birth and up to 12 weeks afterward. It is important to note that bleeding after a vaginal delivery or cesarean section is normal; however, the amount of bleeding and clinical symptoms is the determining factor for normal to abnormal hemorrhagic bleeding.

In 2017, the American College of Obstetricians and Gynecologists (ACOG) revised its definition of PPH to include the following: A cumulative loss of blood greater than or equal to (≥) 1000 mL or bleeding associated with signs and symptoms of low blood volume (hypovolemia) within 24 hours of birth (3). When the birth of a child occurs, the delivery of the placenta follows, and bleeding is typically controlled with two maternal mechanisms. Mechanical hemostasis is achieved with myometrium contraction, constricting the blood vessels to the uterus.

The second mechanism controlling bleeding is local decidual hemostatic factors, platelets, to cause clotting (3).PPH can become an obstetric emergency because of the ample supply of blood volume to the uterus ranging from 500-700 mL/min, which equates to around 15% of the maternal cardiac output  (3). Disrupting these mechanisms from functioning and using assessment tools early on can be for potential PPH management.  

Quiz Questions

Self Quiz

Ask yourself...

  1. Did you use estimated or quantified blood loss measures?  
  2. What was the blood loss amount for patients you have encountered? 
  3. What were each patient’s signs and symptoms? What were the causes?  
  4. What treatment methods did you use? 

Assessment 

The Joint Commission requires an evidence-based assessment tool to determine maternal PPH risk in admission and postpartum units (3). There is a wide range of assessment tools in the U.S. currently being utilized to decrease the rates of hemorrhage-related maternal deaths. The key to assessing PPH management is starting early, before delivery.

One such assessment tool, the Safe Motherhood Initiative, developed by ACOG, is used during the prenatal, antepartum, admission to L&D, and intrapartum (6). These assessments are provided in detail below, and each assessment discusses risk factors during those periods (prenatal, antepartum, L & D admission, and intrapartum) as well as intervention and management steps. (7)(8).

Patients should also be educated during their hospital stay and before discharge on signs and symptoms and what to do if PPH were to occur. Having an assessment tool that identifies potential risk factors and outlines preparatory interventions for when those risk factors are present is vital. This will enable prompt management and treatment.  

Quiz Questions

Self Quiz

Ask yourself...

  1. Do you currently use any screening tools for risk factors in pregnant patients? 
  2. Are they built into other assessments or stand-alone assessments? 
  3. How often and when do you screen?  
  4. Have you performed any nursing interventions based on the identified risk factors? 
  5. Have you ever used PPH assessments based on the period the patient was in (antepartum, Labor and Delivery, Intrapartum)? 

 

Prenatal & Antepartum Assessment (8) 

Prenatal

Risk Factors: 

  • Pre-pregnancy BMI over 50 
  • Suspected placenta percreta/previa/increta/accreta 
  • Clinically significant bleeding disorder 
  • Other significant surgical/medical risks (consider patients who refuse transfusion) 

Intervention 

  • Transfer to the appropriate level of care for delivery 
Antepartum

Risk Factors:  

  • Placenta previa (Timing of delivery 36 0/7-37 6/7) 
  • Placenta accreta (Timing of delivery 34 0/7-35 6/7) 
  • Prior cesarean (classical) (Timing of delivery 36 0/7-37 6/7) 
  • Prior myomectomy (Timing of delivery 37 0/7-38 6/7) 
  • Prior myomectomy, if extensive (Timing of delivery 36-37) 
Placenta accreta management
  • The placental location for one or more previous C-sections must be documented before delivery. Patients at higher risk of placenta accreta should;  
  • Obtain proper imaging to assess risk before delivery 
  • Be transferred to the appropriate level of care for delivery if accreta is suspected 

 

 

Labor and Delivery Admission and Intrapartum Assessment

Labor and Delivery Admission 

Risk Factors for Medium Risk:  

  • Prior C-section, uterine surgery, or multiple laparotomies 
  • Multiple gestation pregnancy 
  • Greater than four births 
  • Previous PPH 
  • Large myomas 
  • Estimated fetal weight > 4000 grams 
  • BMI > 40 
  • Hematocrit <30% and other risks 

Intervention:  

  • Type and SCREEN, review protocol 

 

Risk Factors for High Risk:  

  • Placenta previa/low-lying  
  • Known coagulopathy 
  • Active bleeding 
  • Plateltet count <70,000 
  • Suspected percreta/accreta 
  • Two or more medium-risk factors 

Intervention 

  • Type and CROSS, review protocol  

 

Intrapartum

Risk Factors for Medium Risk:  

  • Chorioamnionitis 
  • Oxytocin longer than 24 hours 
  • Prolonged 2nd stage 
  • Magnesium sulfate  

Intervention:  

  • Type and SCREEN, review protocol  

 

Risk Factors for High Risk:  

  • New active bleeding 
  • Two or more medium (admission and intrapartum) risk factors 

Intervention 

  • Type and CROSS, review protocol  
Quiz Questions

Self Quiz

Ask yourself...

  1. Think about each of these screening questions. Why would each of them be considered a risk factor for patients? 
  2. Think about patients you have cared for who have been delivered previously. What were the outcomes for these types of deliveries or complications?  
  3. Did any of them experience bleeding more often than other patients?  
  4. Was there any delay in patient care that could have been prevented with a screening tool to prepare for possible bleeding? 

Identification 

Now that we have screened our patient for risk factors for hemorrhage potential, we need to recognize if our patient is within normal limits or has PPH. If bleeding is identified, we will need to acknowledge the severity of the bleeding based on collected data and defined criteria by your facility. Postpartum maternal assessments are performed to prevent PPH and include vital signs, uterine fundal tone/location, lochia, and perineal and labial area evaluation (2). The vital signs, including temperature, pulse, blood pressure, and respirations, should be done every 15 minutes for the first 2 hours after birth. The uterine fundus and lochia should also be assessed with each vital sign assessment (2). Additional vital signs and fundal checks could also be done depending on facility protocol.  

  • What is your current practice for calculating blood loss? 
  • How often are your postpartum maternal assessments? 
  • When do you start? When do you stop calculating?  
  • What items are used to determine blood loss?  
  • Do you assess for color, clot formation, and flow? 

When assessing for bleeding, using a quantified blood loss (QBL) method versus estimated blood loss (EBL) will provide you with a more accurate clinical picture. The use of EBL methods can delay the time-sensitive initiation of life-saving interventions and is commonly found among maternal morbidity and mortality cases. QBL describes a systematic use of weighing scales, volumetric containers, and computerized images to identify blood loss (3) accurately. Options to use in QBL include but are not limited to volumetry, gravimetry, colorimetry with artificial intelligence, and visual aids. It is important to note that the clinician should remember to account for fluids other than blood (urine, irrigation fluid, and amniotic fluid) that are collected or absorbed (3).  

California Maternal Quality Care Collaborative (CMQCC) and the American College of Obstetrics and Gynecology (ACOG) have developed patient hemorrhage bundles that detail various definitive stages of bleeding. The resources below define bleeding stages, including signs and symptoms, and also include interventions necessary to advise clinicians when to increase or decrease the severity stage (1)(5).  

California Maternal Quality Care Collaborative Staging (5) 

Stage Signs/Symptoms
0
  • All birthing women
1
  • Vaginal EBL > 500mL 
  • Cesarean EBL > 1000mL 
  • Vital Sign changes 
  • 15 percent 
  • Heart rate > 110 beats per minute 
  • Blood pressure < 85/46 
  • O2 saturation < 95% 
2
  • Continued bleeding  <1500 
3
  • Continues bleeding <1500 mL 
  • More than 2 units of PRBC 
  • Unstable Vital Signs 
  • Suspicion of DIC 

American College of Obstetrics and Gynecology (1):

Stage Signs/Symptoms
1
  • Blood loss > 1000mL 
  • Normal vital signs and lab values 
  • Vaginal deliveries 500-999mL should be treated in this stage 
2
  • Continued bleeding up to 1500 mL 
    • 2 uterotonic medications 
  • Normal vital signs and lab values 
3
  • Continued bleeding up to >1500 mL 
  • 2 RBCs given 
  • At risk for occult bleeding/coagulopathy 
  • Abnormal vital signs or labs 
  • Oliguria 
4
  • Cardiovascular collapse 
  • Massive hemorrhage 
  • Profound hypovolemic shock 
  • Amniotic fluid embolism 
Quiz Questions

Self Quiz

Ask yourself...

  1. Do you currently use a tool to identify the severity of the hemorrhage? 
  2. Is there a protocol for when to determine the worsening or stabilization of the patient’s condition? 

Treatment 

Since we have assessed for risk factors, we have recognized the occurrence and severity of bleeding, and we need to treat it. Lets begin by looking at possible causative factors for the occurring hemorrhage:

Causative Factors-Consider 4 T’s (3): 

  • Tone- uterine atony 
  • Trauma- lacerations of the cervix, vaginal tissue, the blood vessel of the uterus 
  • Tissue- Retained placenta 
  • Thrombin- bleeding disorders 

Have you experienced any patients with tone, trauma, tissue, or thrombin occurrences?  

Did any of them hemorrhage or have increased bleeding?  

Were there any specific interventions utilized prior to delivery or after because of them?  

Order sets and interventions aligning with the severity will help guide healthcare teams in effective PPH management and treatment.  

Treatment provided promptly is crucial because 90 % of maternal deaths related to PPH occur within 4 hours of delivery (2)(Belfort). PPH treatment encompasses a range of interventions, such as pharmacological, surgical, and interventional endovascular procedures, blood bank assistance, nonsurgical methods, and consultations (3). 

Pharmacological treatment options(3)

 

First line

  • Oxytocin

Second line

  • Ergots (Methylergonovine)
  • Carboprost

Adjunctive agents

  • Tranexamic acid
  • Recombinant human factor VIIa
  • Misoprostol

 

Surgical interventions(3):
  • Laceration repair
  • Curettage
  • Uterus compression suture and uterine artery ligation
  • Utero-ovarian artery cross clamp or ligation
  • Pelvic packing
  • Uterine tourniquet
  • Focal myometrial excision
  • Fibrin glues and patches to cover areas of oozing and to promote clotting
  • Figure 8 Sutures or other hemostatic sutures in the placental bed
  • Resuscitative endovascular balloon occlusion of the aorta (REBOA)
  • Hypogastric artery ligation
  • Aortic/iliac artery compression
  • Total hysterectomy
  • Supracervical hysterectomy

 

Interventional Endovascular procedures(3):
  • Selective arterial embolization
  • Intermittent aortic and common iliac artery balloon occlusion

 

Blood bank interventions (3):
  • Platelets
  • Packed red blood cells (PRBCs)
  • Cryoprecipitate
  • Fresh frozen plasma (FFP)

 

Nonsurgical interventions(3):
  • Uterine massage
  • IV fluids
  • Intrauterine tamponade, including;
  • Intrauterine balloon, Sengstaken-Blakemore tube, or bladder catheter bulb
  • Intrauterine vacuum
  • Uterine packing

 

Consultations(3);
  • General surgery
  • Anesthesia team
  • Interventional Radiology (IR)
  • Urology
  • Gynecology Oncology
  • Trauma surgery

The overall goals of treating PPH are to eliminate the underlying obstetric cause, avoid or reverse coagulopathy, restore or preserve adequate tissue oxygenation, and restore adequate circulatory volume (3).

The CCQCC and ACOG scoring tools helped us recognize the severity of bleeding; we also developed interventions within each stage to guide your treatment. While these interventions and treatments are outlined for each stage, please consider your scope of practice in your state.

 

 

California Maternal Quality Care Collaborative Treatment Plan (5): 

Stage Interventions Medications Blood Bank
0
  • Assess for risk factors 
  • Measure cumulative quantitative blood loss on every birth 
  • Fundal massage 
  • Active management in 3rd stage of labor with oxytocin 
  • Medium risk-type and screen 
  • High risk- type and cross 2 units 
1
  • Activate hemorrhage protocol and checklist 
  • Notify care team 
  • Vitals signs q5 minutes 
  • Weight blood materials 
  • Careful inspection of vaginal walls, cervix, uterine cavity, & placenta 
  • IV access 
  • Empty bladder 
  • Repeat fundal massage 
  • Increase IV fluid and oxytocin rate 
  • Uterotonic drugs 
  • Type and cross 2 units, if not completed 
2
  • OB to bedside 
  • Obtain extra help 
  • Vitals signs and cumulative blood loss calculations every 5-10 minutes 
  • Weight bloody materials 
  • Send additional d/c labs 
  • Move patient to L/D or OR 
  • Evaluate for special causes 
  • Complete evaluation of vaginal walls, cervix, uterine cavity, & placenta 
  • Repair any tears-provider 
  • D/C any retained placenta 
  • Place intrauterine balloon 
  • Selective interventional radiology 
  • Bimanual fundal massage 
  • Second IV access line 
  • Inspect broad ligament and posterior uterus for cesarean 
  • Uterotonic medications 
  • Notify blood bank of postpartum hemorrhage 
  • Bring two units to bedside and transfuse with clinical indications 
  • Use blood warmer 
  • Consider thawing two units of FFP 
  • Determine need for additional RBCs or COAG products 
3
  • Obtain additional help 
  • Social worker for family support 
  • Repeat labs 
  • Central line 
  • Fluid warmer 
  • Upper body warming 
  • SCDs 
  • Hysterectomy 
  • B-Lynch suture 
  • Uterine artery ligation 
 
  • Initiate massive transfusion protocol 

American College of Obstetrics and Gynecology (1):

Stage Interventions Medications Blood Bank
1
  • Ensure IV access with a 16 or 18-gauge 
  •  Increase IV fluids (crystalloids without oxytocin) 
  • Insert indwelling catheter 
  • Fundal massage 
  • Review possible etiology and treat 
  • Prepare OR if clinically indicated 

 

  • Oxytocin 
  • Methergine 
  • Hemabate 
  • Cytotec 
  •  Confirm type and screen 
  • Consider cross-matching two units of PRBCs 
2
  • Place a second IV line (with a 16 or 18-gauge) 
  • Obtain additional help 
  • Draw STAT labs (Fibrinogen, Coags, CBC) 
  • Prepare OR for possible surgical interventions 
  • B-Lynch suture 
  • Bakri balloon  
  • Uterine artery ligation 
  • Hysterectomy 
  • If uterine atony is determined, place a uterine tamponade balloon 
  • Escalate therapy with the overall goal of hemostasis 
  • Continue medications from stage 1; consider Tranexamic Acid (TXA) 
  • Thaw two units of FFP 
  • Obtain two units of PRBCs
  • Transfuse based on clinical signs and symptoms, bypass labs 
  •  
3
  • Escalate interventions 
  • Move to OR 
  • Obtain additional help 
  • Declare the current clinical status/assessment (vitals, etiology, cumulative blood loss)  
  • Establish and communicate the treatment plan 
  • To achieve hemostasis, interventions are based on the etiology of PPH 
  • Continue medications from stage 1; consider Tranexamic Acid (TXA)
  • Pitocin, Methergine, Hemabatem Carboprost, Cytotec

 

  • Initiate massive transfusion protocol when clinically appropriate
4
  • Obtain any additional help available 
  • Aggressive massive transfusion management 
  • Utilize ACLS protocols if indicated 
  • Consider immediate surgical intervention through hysterectomy 
   
Quiz Questions

Self Quiz

Ask yourself...

  • Have you ever used a staging system to guide treatment in hemorrhaging patients? If not, how was the patient outcome?  
  • Did the bleeding treatment run smoothly amongst the care team? 
  •  Would a staging system for hemorrhage help with the efficiency or effectiveness of patient care? If you have used one, was it easy to use and follow?  
  • Did a staging system help guide the treatment of bleeding?  
  • Did a staging system make it more challenging to treat hemorrhaging patients? 

Recovery 

Once the patient is stabilized after the PPH management and treatment protocols are followed, we must focus on recovery. According to your hospital policy, the team should continue to provide heightened assessment surveillance on post-hemorrhage patients through lab work, vital signs, fundal assessments, lochia assessments, and patient symptoms. Measures including documentation, patient education, and staff mock-ups or drills will allow continued success in reducing rising PPH rates.  

Performing post-event debriefs is a handy tool for assisting with process improvements and providing educational guidance. Debriefs should be completed once patients are cared for, but events are still recent for the care team to remember.  

During the actual hemorrhagic event, documentation can become more complex with implementing appropriate and timely interventions and assessments. An events recorder and paper documentation will focus on patients and establish a reference for noted events to provide efficient patient care. Having documented assessments leading to implemented interventions, medication administrations, and blood bank activations will give an event timeline of patient status. 

Patient education should be provided to all obstetric postpartum patients regardless of hemorrhage occurrence. All patients should be educated on when to call healthcare providers when to call 911, and normal versus abnormal bleeding. 

Education tips may include:  

  • Instruct patients to expect to bleed and cramp over the next 4-6 weeks. Give detailed instructions on how much bleeding to expect and how much is abnormal.  
  • The color of the bleed changes from red to pink to brown 
  • Rising to a standing position from sitting or lying may create a gush “gush” due to the pooling of blood in the vaginal vault and gravity releasing it when standing 
  • Bleeding that is soaking through a peri-pad in one hour or a blood clot the size of an egg or larger needs immediate attention (9) 

Staff education is vital in facilitating efficient and effective PPH management. Knowledge of PPH risk factors will facilitate planning and readiness for these occurrences. Ensuring staff are familiar with hospital policy and procedure for PPH and uterotonic medications, treatment supplies, and hemorrhage carts with included contents enables prompt patient response. Creating outlined scoring methods to implement interventions based on severity allows for objective data utilization to maintain patient clinical well-being. Having quarterly education and drills for staff ensures competency, teamwork, and communication during these high-stress events.  

 

Quiz Questions

Self Quiz

Ask yourself...

  1. How is education provided to postpartum patients you have cared for?  
  2. Have you ever participated in hemorrhage mocks, drills, or skill labs? Did these improve or change your practice in any way?  

Conclusion 

When we can prevent a complication, we react with assessment, intervention, and education to ensure our nursing care promotes the highest quality patient care. Utilizing this method enables nurses to prepare for the possibility of complications, whether they occur or not. PPH is the leading cause of maternal death(4), and ensuring that resources, assessments, and educational opportunities are available will provide us with the necessary tools to reduce the occurrence of life-altering events in the new mother, baby, and family.

References + Disclaimer

  1. ACOG: Obstetric Hemorrhage Checklist. ACOG, https://www.acog.org/-/media/project/acog/acogorg/files/forms/districts/smi-ob-hemorrhage-bundle-hemorrhage-checklist.pdf (accessed April 20, 2024).  
  2. Assessment: Postpartum patients (maternal-newborn) – CE,” Elsevier’s Healthcare Hub, https://elsevier.health/en-US/preview/reproductive-health/assessment-postpartum-patients-ce (accessed April 20, 2024). 
  3. Belfort, M. A. (2024, February 06). Overview of postpartum hemorrhage. UpToDate. https://www.uptodate.com/contents/overview-of-postpartum-hemorrhage?search=postpartum+hemorrhage+treatment&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H2519343764  
  4. John R Smith, M. (2021, April 01). Postpartum hemorrhage. Retrieved April 23, 2024, from https://emedicine.medscape.com/article/275038-overview 
  5. OB hemorrhage toolkit v 2.0. (n.d.). Retrieved April 23, 2024, from https://www.cmqcc.org/resources-tool-kits/toolkits/ob-hemorrhage-toolkit 
  6. Obstetric hemorrhage. ACOG, https://www.acog.org/community/districts-and-sections/district-ii/programs-and-resources/safe-motherhood-initiative/obstetric-hemorrhage (accessed April 19, 2024). 
  7. Obstetric hemorrhage: Risk Assessment Tables for Labor and Delivery Admission and Intrapartum,” ACOG, https://www.acog.org/community/districts-and-sections/district-ii/programs-and-resources/safe-motherhood-initiative/obstetric-hemorrhage (accessed April 19, 2024). 
  8. Obstetric hemorrhage: Risk Assessment Tables for Prenatal and Antepartum. ACOG, https://www.acog.org/community/districts-and-sections/district-ii/programs-and-resources/safe-motherhood-initiative/obstetric-hemorrhage (accessed April 19, 2024).  
  9. Post-birth warning signs education program. (2021, February 12). Retrieved April 23, 2024, from https://www.awhonn.org/education/hospital-products/post-birth-warning-signs-education-program/ 

 

Disclaimer:

Use of Course Content. The courses provided by NCC are based on industry knowledge and input from professional nurses, experts, practitioners, and other individuals and institutions. The information presented in this course is intended solely for the use of healthcare professionals taking this course, for credit, from NCC. The information is designed to assist healthcare professionals, including nurses, in addressing issues associated with healthcare. The information provided in this course is general in nature and is not designed to address any specific situation. This publication in no way absolves facilities of their responsibility for the appropriate orientation of healthcare professionals. Hospitals or other organizations using this publication as a part of their own orientation processes should review the contents of this publication to ensure accuracy and compliance before using this publication. Knowledge, procedures or insight gained from the Student in the course of taking classes provided by NCC may be used at the Student’s discretion during their course of work or otherwise in a professional capacity. The Student understands and agrees that NCC shall not be held liable for any acts, errors, advice or omissions provided by the Student based on knowledge or advice acquired by NCC. The Student is solely responsible for his/her own actions, even if information and/or education was acquired from a NCC course pertaining to that action or actions. By clicking “complete” you are agreeing to these terms of use.

 

Complete Survey

Give us your thoughts and feedback

Click Complete

To receive your certificate


Want to earn credit for this course? Sign up (new users) or Log in (existing users) to complete this course for credit and receive your certificate instantly.